TickerGuard
Buy Day today: Poor (57) Mixed market breadth · today: Nonfarm Payrolls (September)
TLRY

Tilray Inc

Healthcare · Drug Manufacturers - Specialty & Generic

3.60$ -4.8% vs. previous close Closing price · As of: Oct 1, 2026

Statements

Income Statement

Tilray Inc (TLRY) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 282 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement TLRY
Line item Q2 16 Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
1.8 3.3 2.9 2.9 4.0 4.8 6.6 6.3 6.9 10 16 17 71 71 93 73 51 121 101 184 168 199 193 193 201 194 198 184 240 262 256 313 270 295 268 308 288 304 282 282 1,156
0.4 0.3 0.6 0.9 -0.1 -1.4 1.4 1.0 -3.6 -0.3 12 15 50 46 70 50 51 96 73 174 117 157 142 202 137 137 214 117 180 198 189 201 189 209 193 215 209 224 207 197 837
1.3 2.2 2.3 2.0 4.1 6.3 3.8 5.2 11 8.2 4.5 2.6 21 26 23 22 0.4 25 27 10.0 51 42 51 -8.5 64 58 -16 67 60 64 67 112 81 86 75 93 79 80 75 84 319
0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.2 0.5 0.8 0.1 0.3 0.1 0.3 0.9 0.1 0.2 0.4 0.8 0.7 0.2 0.1 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.5 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.4
0.5 0.7 0.8 1.4 1.4 3.4 2.5 5.3 8.5 7.5 11 13 15 15 18 15 13 49 22 5.5 49 43 55 73 53 38 53 48 55 59 54 65 60 65 57 50 57 72 69 61 258
1.4 1.8 2.0 4.7 2.6 5.2 4.5 10 16 14 20 20 33 23 41 59 31 69 48 84 120 113 74 581 92 128 1,626 157 106 121 178 135 130 145 1,173 2,074 76 111 102 89 378
0.0 -6.2 0.3 -2.6 1.5 1.1 -0.9 -5.0 -5.0 -20 -16 -18 -12 2.3 -18 -36 -31 -54 -20 -74 -69 -71 -23 -589 -28 -70 -1,642 -90 -47 -57 -111 -23 -49 -59 -1,098 -1,981 2.9 -31 -27 -4.5 -60
0.1 0.0 0.1 0.3 0.1 0.3 0.2 0.2 0.2 0.3 0.6 6.5 3.2 5.2 7.1 10 10 8.2 9.0 14 10 13 2.9 22 5.8 3.1 1.4 5.0 13 12 12 13 13 11 12 5.4 9.2 7.5 6.8 6.6 30
0.0 -9.4 0.5 2.8 -1.9 15 5.2 10 -4.2 -19 47 -25 9.6 11 -189 -53 -1.9 -278 -5.0 55 -30 0.2 64 -582 -77 -99 -1,642 -112 -66 -67 -146 -59 -46 -116 -1,144 -1,912 -1.1 -56 -32 -24 -113
0.9 0.0 0.1 -4.4 0.6 3.0 0.2 2.5 -1.1 0.0 6.0 -3.0 0.2 1.5 -4.7 -1.2 0.4 4.8 -2.1 -0.4 4.8 -7.3 -2.3 -4.8 9.5 -16 -15 8.1 9.8 -4.6 -3.9 -38 1.2 2.8 1.7 -172 -3.1 5.0 2.7 14 18
1.0 0.7 0.7 2.8 -2.0 12 5.0 7.9 -13 -19 41 -22 9.4 9.3 -184 -52 -2.3 -283 -2.9 55 -42 -0.3 55 -603 -96 -91 -1,593 -139 -97 -66 -126 -43 -53 -119 -1,140 -1,747 -0.4 -63 -36 -50 -149
0.2 0.8 0.8 3.2 -1.5 16 4.8 11 -1.8 18 51 -16 17 21 -168 -44 -23 -330 -11 99 -3.6 61 114 -509 -26 -61 -1,594 -45 -11 -13 -90 15 11 -58 -1,084 -1,844 30 -26 -2.1 15 16

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?